Page 4 - Peptide Drug Candidate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peptide drug candidate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peptide Drug Candidate Today - Breaking & Trending Today

Oncopeptides presents new scientific data at the Annual American Society of Hematology Meeting ASH

STOCKHOLM, Dec. 12, 2022 /PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company. ....

United States , New Orleans , United Kingdom , Rolf Gulliksen , Klaas Bakker , American Society Of Hematology Meeting , American Society Of Hematology , European Union , Global Head Of Corporate Communications , Nasdaq Stockholm , Annual American Society , Hematology Meeting , Peptide Drug Conjugate , Chief Medical , American Society , Global Head , Corporate Communications , Peptide Drug Candidate , Marketing Authorization , Mid Cap ,

Oncopeptides provides update on Pepaxto US marketing authorization

/PRNewswire/ Oncopeptides AB (publ) (NASDAQ Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat. ....

United Kingdom , Rolf Gulliksen , Jakob Lindberg , European Union , Drug Administration , European Medicines Agency , Global Head Of Corporate Communications , Healthcare Products Regulatory Agency , Killer Engagers , Global Head , Corporate Communications , Peptide Drug Candidate , Marketing Authorization , Mid Cap , Nasdaq Stockholm , Oncopeptides Ab ,

Oncopeptides AB: Oncopeptides provides update on Pepaxto US marketing authorization

STOCKHOLM, Dec. 7, 2022 /PRNewswire/ Oncopeptides AB (publ) (NASDAQ Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological ....

United Kingdom , Rolf Gulliksen , Jakob Lindberg , European Union , Drug Administration , European Medicines Agency , Global Head Of Corporate Communications , Healthcare Products Regulatory Agency , Killer Engagers , Global Head , Corporate Communications , Peptide Drug Candidate , Marketing Authorization , Mid Cap , Nasdaq Stockholm ,

Oncopeptides AB: Oncopeptides enters into a renewed loan facility agreement of up to €30 million with the European Investment Bank

STOCKHOLM, Nov. 25, 2022 /PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological ....

United Kingdom , Rolf Gulliksen , Jakob Lindberg , European Union , Global Head Of Corporate Communications , European Investment Bank , Nasdaq Stockholm , European Economic Area , Global Head , Corporate Communications , Peptide Drug Candidate , Marketing Authorization , Mid Cap , European Investment ,

Oncopeptides enters into a renewed loan facility agreement of up to €30 million with the European Investment Bank

/PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat. ....

United Kingdom , Rolf Gulliksen , Jakob Lindberg , European Union , Global Head Of Corporate Communications , European Investment Bank , Nasdaq Stockholm , European Economic Area , Global Head , Corporate Communications , Peptide Drug Candidate , Marketing Authorization , Mid Cap , European Investment ,